metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Tiroidectomía subtotal con resto volumétrico unilateral en la cirugía de la e...
Información de la revista
Vol. 73. Núm. 4.
Páginas 206-212 (abril 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 73. Núm. 4.
Páginas 206-212 (abril 2003)
Acceso a texto completo
Tiroidectomía subtotal con resto volumétrico unilateral en la cirugía de la enfermedad de Graves-Basedow
Subtotal thyroidectomy with unilateral volumetric remnant in the surgical treatment of Graves-Basedow disease
Visitas
7916
Álvaro Larrad Jiménez1
Autor para correspondencia
larrad@inicia.es

Correspondencia: Dr. A. Larrad Jiménez. Rafael Bergamín, 12, atc. C, esc. izqda. 28043 Madrid. España.
, Pedro de Quadros Borrajo, Inmaculada Ramos García, Carlos Sánchez-Cabezudo
Unidad de Cirugía Endocrinometabólica. Clínica Ruber. Madrid. España
Este artículo ha recibido
Información del artículo
Resumen
Objetivo

Analizar la validez funcional del tratamiento quirúrgico de la enfermedad de Graves-Basedow mediante tiroidectomía subtotal con resto diseñado mediante cálculo volumétrico, y los posibles factores de influencia de hipotiroidismo.

Pacientes y métodos

Estudio prospectivo con valoración retrospectiva de 77 pacientes operados dejando un resto único de 4-5 ×2 ×1,5-2 cm, calculado mediante la medida de los tres diámetros. Se analizan los porcentajes de hiper e hipotiroidismo posquirúrgico, la incidencia acumulada de hipotiroidismo mediante el método de Kaplan-Meyer, y el estudio de los posibles factores predictivos mediante análisis univariante y multivariante de las variables relacionadas con el tiempo mediante el método de Mantel-Cox, calculándose los riesgos relativos con intervalos de confianza del 95% y la sensibilidad pronóstica mediante el área bajo la curva ROC.

Resultados

Con restos unilaterales de 8 ml y un seguimiento medio de 69,4 (34) meses, el porcentaje de recidiva es del 2,59% y el de hipotiroidismo del 38,6%. El 31% de los hipotiroidismos fueron precoces (3-6 meses) y el 68,9%, subclínicos y tardíos (24- 36 meses), estabilizándose su incidencia actuarial a partir de los 48 meses. El único factor predictivo de hipotiroidismo tardío en el análisis multivariante es la alta concentración postoperatoria de anticuerpos antiperoxidasa, con un riesgo relativo de 6,5.

Conclusiones

El cálculo volumétrico del resto tiroideo aporta unos resultados muy satisfactorios en el tratamiento quirúrgico de la enfermedad de Graves- Basedow. Sería aconsejable que los tamaños de los restos se expresaran en volumen real en vez de en la más inexacta medida en gramos, lo que permitiría estandarizar la técnica de medida y comparar correctamente los resultados de los distintos grupos.

Palabras clave:
Hipertiroidismo
Enfermedad de Graves- Basedow
Cirugía del hipertiroidismo
Volumen tiroideo
Objective

To analyze the functional validity of the surgical treatment of Graves-Basedow disease with subtotal thyroidectomy with a remnant designed through volumetric calculation and the possible predictive factors for hypothyroidism.

Patients and methods

We performed a prospective study with retrospective evaluation of 77 patients who underwent surgery leaving a single 4-5 ×2 ×1.5-2 cm remnant calculated by measuring the three diameters. The percentages of hyper and hypothyroidism were analyzed. The accumulated incidence of hypothyroidism was calculated using the Kaplan-Meyer method and the possible predictive factors were estimated using uni and multivariate analysis of timerelated variables through the Mantel-Cox method. Relative risks were calculated using 95% confidence intervals and prognostic sensitivity was measured using the area under the ROC curve.

Results

With unilateral remnants of 8 ml and a mean follow-up of 69.4 (34) months, the percentage of recurrence was 2.59% and that of hypothyroidism was 38.6%. Thirty-one percent of cases of hypothyroidism were early (3-6 months) and 68.9% were subclinical and late (24-36 months) and its actuarial incidence was determined at 48 months. In the multivariate analysis, the only predictive factor for late hypothyroidism was a high postoperative concentration of antiperoxidase antibodies, with a relative risk of 6.5.

Conclusions

Volumetric calculation of the thyroid remnant provides highly satisfactory results in the surgical treatment of Graves-Basedow disease. We recommend that remnant size be expressed in real volume instead of in the less exact measurement in grams, which would enable standardization of the measurement technique and accurate comparison of the results of different groups.

Key words:
Hiperthyroidism
Graves-Basedow disease
Hiperthyroidism surgery
Thiroid volumen
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.A. Franklyn.
Management guidelines for hyperthyroidism.
Baillière’s Clin Endocrinol Metab, 11 (1997), pp. 561-584
[2.]
A.P. Weetman.
Medical Progress: Graves’ disease.
N Engl J Med, 343 (2000), pp. 1236-1248
[3.]
T. Harada, K. Shimoaka, T. Mimura, K. Ito.
Current treatment of Graves’ disease.
Surg Clin North Am, 67 (1987), pp. 299-314
[4.]
S.A. Folk.
Surgical treatment of hyperthyroidism.
pp. 319-340
[5.]
T. Harada, M. Katagiri, K. Ito.
Hyperthyroidism: Graves’ disease and toxic nodular goiter.
pp. 47-53
[6.]
O. Alsanea, O.H. Clark.
Treatement of Graves’ disease: the advantages of surgery.
Endocrinol Metab Clin North Am, 29 (2000), pp. 321-337
[7.]
M. Amat, J.M. Gómez, S. Biondo, A. Rafecas, E. Jaurrieta.
Factores pronósticos en el resultado funcional del tratamiento quirúrgico de la enfermedad de Graves-Basedow.
Med Clin (Barc), 116 (2001), pp. 487-490
[8.]
T.K. Palit, C.C. Miller, D.M. Miltenburg.
The efficacy of thyroidectomy for Graves’ disease: a meta-analysis.
J Surg Res, 90 (2000), pp. 161-165
[9.]
M. Hermann, R. Roka, B. Richter, M. Freissmuth.
Early relapse after operation for Graves’ disease: postoperative hormone kinetics and outcome after subtotal, near-total and total thyroidectomy.
Surgery, 124 (1998), pp. 894-900
[10.]
E.L. Cusick, Z.H. Krukowski, N.A. Matheson.
Outcome of surgery for Graves’ disease re-examined.
Br J Surg, 74 (1987), pp. 780-783
[11.]
P. Miccoli, P. Vitti, T. Rago, P. Iacconi, L. Bartalena, F. Bogazzi, et al.
Surgical treatment of Graves’ disease: subtotal or total thyroidectomy.
Surgery, 120 (1996), pp. 1020-1025
[12.]
A.J. Hedley, P.D. Bewsher, S.J. Jones, A.S.M. Khir, P. Clements, N.A. Matheson, et al.
Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: Implications for long term follow-up.
Br J Surg, 70 (1983), pp. 740-743
[13.]
L. Fernández-Cruz.
Radioyodo o cirugía en el tratamiento de la tirotoxicosis.
Med Clin (Barc), 82 (1984), pp. 637-638
[14.]
F. Menegaux, T. Ruprecht, J.P. Chigot.
The surgical treatment of Graves’ disease.
Surg Ginecol Obstet, 176 (1993), pp. 277-282
[15.]
N.J. Leech, C.M. Dayan.
Controversies in the management of Graves’ disease.
Clin Endocrinol, 49 (1998), pp. 273-280
[16.]
P. Blondeau.
Masson, (1996),
[17.]
J. Sánchez Beorlegui, F. Lamata Hernández, J. Lagos Lizán, R. Cerdán Pascual, F.A. García Gil, M. Matínez Díez, et al.
Tiroidectomía total frente a subtotal en el tratamiento quirúrgico de la enfermedad de Graves-Basedow.
Cir Esp, 65 (1999), pp. 110-115
[18.]
J. Marescaux.
Thyroïde.
pp. 13-53
[19.]
A.J. Edis, L.A. Ayala, R.H. Egdhal.
Springer-Verlag, (1975),
[20.]
P. Gil Gil, G. Páramo Fernández.
El resurgir del tratamiento quirúrgico en la enfermedad de Graves-Basedow.
Cir Esp, 65 (1999), pp. 89-90
[21.]
C. Marcocci, G. Bruno-Bossio, L. Manetti, M.L. Tanda, P. Miccoli, P. Iacconi, et al.
The course of Graves’ ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
Clin Endocrinol (Oxf), 51 (1999), pp. 503-508
[22.]
A. Larrad Jiménez, E. Pérez Merino, C. García Menéndez, E. Domínguez Comesaña, M. Mingo Zapatero.
El test de TRH en la valoración funcional del enfermo operado de hipertiroidismo.
Cir Esp, 44 (1988), pp. 378-392
[23.]
R.L. Rossi, B. Cady.
Surgical anatomy.
pp. 13-30
[24.]
J.M. Palacios Mateos.
Exploración clínica y funcional del tiroides.
pp. 152-171
[25.]
L. Hegedüs.
Thyroid ultrasound.
Endocrinol Metab Clin North Am, 30 (2001), pp. 339-360
[26.]
L. Andäker, K. Johansson, S. Smeds, S. Lennquist.
Surgery for hypethyroidism: hemithyroidectomy plus contralateral resection or bilateral resection? A prospective randomised study of postoperative complications and long-term results.
World J Surg, 16 (1992), pp. 765-769
[27.]
Jp. Ozoux, L. De Calan, G. Portier, B. Rivallain, Jp. Favre, A. Rovier, et al.
Surgical treatment of Graves’ disease.
Am J Surg, 156 (1988), pp. 177-181
[28.]
G.P. Sadler, M.H. Wheeler.
The thyroid gland.
pp. 83
[29.]
S.A. Folk.
Metabolic complications of thyroid surgery: hypocalcemia and hypoparathyroidism; hypocalcitoninemia; and hypothyroidism and hyperthyroidism.
pp. 717-738
[30.]
S.A. Folk.
Complications of thyroid surgery: an overview.
pp. 697-704
[31.]
M. Hermann, R. Roka, B. Richter, K. Koriska, S. Gobl, M. Freissmuth.
Reoperation as treatment of relapse after subtotal thyroidectomy in Graves’ disease.
Surgery, 125 (1999), pp. 522-528
[32.]
J. Witte, P.E. Goreztki, C. Dotzenrath, D. Simon, P. Felis, M. Neubaner, et al.
Surgery for Graves’ disease: total versus subtotal thyroidectomy. Results of a prospective randomised trial.
W J Surg, 24 (2000), pp. 1303-1311
[33.]
N. Yokoyama, Y. Nagayama, T. Kiriyama, S. Morita, S. Ohtakara, S. Okamoto, et al.
Determination of the volumen of the thyroid gland by a high resolutional ultrasonic scanner.
J Nucl Med, 27 (1986), pp. 1475-1479
[34.]
K. Sugino, T. Mimura, O. Ozaki, Y. Kure, H. Iwasaki, N. Wada, et al.
Early recurrence of hipertyiroidism in patients with Graves’ disease treated by subtotal thyroidectomy.
World J Surg, 19 (1995), pp. 648-652
[35.]
B. Moreno Esteban, J.I. Fernández Navarro, M. Camblor Álvarez.
Hipertiroidismos.
pp. 1249-1280
[36.]
J.E. Pérez Folqués, S. Sancho-Fornos, F.J. Vaqué Urbaneja, P.M. Poves Gil, F. Caro Pérez, J.A. Botella Bolorinos.
Resultados del tratamiento quirúrgico en el hipertiroidismo de la enfermedad de Graves-Basedow.
Cir Esp, 59 (1996), pp. 215-219
[37.]
I. Pavón de Paz, A. Monereo Alonso, S. Monereo Megías, M. Durán Martínez, B. Vega Piñeiro, P. Pardel del Cid, et al.
Evolución de pacientes con enfermedad de Graves tratados con radioyodo. Factores que influyen en la misma.
Endocrinología, 45 (1998), pp. 310-313
[38.]
H. Tamai, K. Kasagi, Y. Takaichi, J. Takamatsu, G. Komaki, S. Matsubayashi, et al.
Development of spontaneous hypothyroidism in patients with Graves’ disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
J Clin Endocrinol Metab, 69 (1989), pp. 49-53
[39.]
P.H. Davies, J.A. Franklyn, J. Daykin, M.C. Sheppard.
The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.
J Clin Endocrinol Metab, 74 (1992), pp. 1189-1194
[40.]
F.F. Chou, P.W. Wang, S.C. Huang.
Results of subtotal thyroidectomy for Graves’ disease.
Thyroid, 9 (1999), pp. 253-257
[41.]
V. Sridama, M. McCormack, E.L. Kaplan, R. Fauchet, L.J. DeGroot.
Long-term follow-up study of compensated low-dose 131I therapy for Graves’ disease.
N Engl J Med, 311 (1984), pp. 426-432
[42.]
Y. Kasuga, S. Kobayashi, M. Fujimori, K. Shingu, K. Asanuna, Y. Hama, et al.
Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves’ disease.
Eur J Surg, 164 (1998), pp. 173-178
[43.]
K. Sugino, K. Ito, O. Ozaki, T. Mimura, H. Iwasaki, N. Wada.
Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves’ disease: Is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves’ disease?.
World J Surg, 23 (1999), pp. 727-731
Copyright © 2003. Asociación Española de Cirujanos
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos